Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Chagas disease cardiomyopathy: immunopathology and genetics
Chagas disease, caused by the protozoan Trypanosoma cruzi, is endemic in Latin America
and affects ca. 10 million people worldwide. About 30% of Chagas disease patients develop …
and affects ca. 10 million people worldwide. About 30% of Chagas disease patients develop …
Chagas disease diagnostic applications: present knowledge and future steps
Chagas disease, caused by the protozoan Trypanosoma cruzi, is a lifelong and debilitating
illness of major significance throughout Latin America and an emergent threat to global …
illness of major significance throughout Latin America and an emergent threat to global …
In-depth evaluation of a case of presumed myocarditis after the second dose of COVID-19 mRNA vaccine
A Muthukumar, M Narasimhan, QZ Li… - Circulation, 2021 - ahajournals.org
A 52-year-old man presented to the emergency department≈ 90 min after the onset of
substernal chest pain. Three days before presentation, he received his second dose of …
substernal chest pain. Three days before presentation, he received his second dose of …
SBC guideline on the diagnosis and treatment of patients with cardiomyopathy of Chagas disease–2023
SciELO - Brasil - Diretriz da SBC sobre Diagnóstico e Tratamento de Pacientes com
Cardiomiopatia da Doença de Chagas – 2023 Diretriz da SBC sobre Diagnóstico e …
Cardiomiopatia da Doença de Chagas – 2023 Diretriz da SBC sobre Diagnóstico e …
Co-exposure of cardiomyocytes to IFN-γ and TNF-α induces mitochondrial dysfunction and nitro-oxidative stress: implications for the pathogenesis of chronic chagas …
Infection by the protozoan Trypanosoma cruzi causes Chagas disease cardiomyopathy
(CCC) and can lead to arrhythmia, heart failure and death. Chagas disease affects 8 million …
(CCC) and can lead to arrhythmia, heart failure and death. Chagas disease affects 8 million …
Prognosis of chronic Chagas heart disease and other pending clinical challenges
RM Torres, D Correia, MCP Nunes… - Memórias do Instituto …, 2022 - SciELO Brasil
In this chapter, the main prognostic markers of Chagas heart disease are addressed, with an
emphasis on the most recent findings and questions, establishing the basis for a broad …
emphasis on the most recent findings and questions, establishing the basis for a broad …
The CXCL10/CXCR3 axis and cardiac inflammation: implications for immunotherapy to treat infectious and noninfectious diseases of the heart
Accumulating evidence reveals involvement of T lymphocytes and adaptive immunity in the
chronic inflammation associated with infectious and noninfectious diseases of the heart …
chronic inflammation associated with infectious and noninfectious diseases of the heart …
[HTML][HTML] Chagas disease: Historic perspective
This review is a perspective on the history of Chagas disease, and it adopts a novel
approach from literary studies, historical documents and the science and epidemiology of …
approach from literary studies, historical documents and the science and epidemiology of …
Evolution, expression and functional analysis of CXCR3 in neuronal and cardiovascular diseases: a narrative review
Chemokines form a sophisticated communication network wherein they maneuver the
spatiotemporal migration of immune cells across a system. These chemical messengers are …
spatiotemporal migration of immune cells across a system. These chemical messengers are …
Chagas disease: Immunology of the disease at a glance
AC Cristovão-Silva, MCA Brelaz-de-Castro… - Cytokine & Growth …, 2021 - Elsevier
Chagas disease is an important neglected disease that affects 6–7 million people
worldwide. The disease has two phases: acute and chronic, in which there are different …
worldwide. The disease has two phases: acute and chronic, in which there are different …